
First results returned from NHS cancer blood test
Two in three patients with suspected cancer symptoms could receive an early diagnosis from a new blood test

The 100,000 Genomes Project and the DDD study: A recap
We look at the background, aims and achievements of two of the most influential genomics studies of the last 15 years

Liquid biopsy: A closer look
We take a deep dive into the genomic test that researchers hope will improve treatment for cancer patients

Evolution of immunity: The genomic link between Covid-19, Crohn’s disease and the Black Death
New research shows that the same genes that helped our ancestors survive the bubonic plague are still hard at work today

A ground-breaking new gene therapy has saved the life of its very first NHS patient
A baby girl is showing no further signs of the fatal genetic disorder metachromatic leukodystrophy after treatment with an exciting new gene therapy

A ‘world first’ in pre-emptive pharmacogenomic testing
Researchers show a 30% reduction in adverse reactions to common clinically prescribed drugs through pharmacogenomic testing

Base editing: What is it and what does it mean for healthcare?
This week, we take an in-depth look at the genome-editing technology that has been making headlines worldwide

Epigenomic studies spotlight new level of cancer evolution
While genomics sets the scene for cancer to grow, it isn’t the only actor – as shown by two studies that cast a light on the role of epigenomics

How epigenomic testing could improve cervical cancer detection
Introducing a new epigenomic test as part of routine cervical screening may help clinicians spot the signature of cervical cancer years before it develops

Cancer therapy involving genome editing cures another child’s leukaemia
We look at a new type of CAR-T cell therapy that, in the world’s first use, has cured a child patient’s leukaemia

Genomics on the horizon: Three predictions for 2023
To kick off the new year, we look at three areas of genomics research and advancement to watch out for in 2023 and beyond

Looking back: Genomics in 2022 (part two)
In the second and final part of our round-up of 2022, we look back at some of the milestones reached this year in genomics research